Edwards Lifesciences Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2016
Total Assets: $4.51B
Liabilities Breakdown FY2016
Total Liabilities: $1.89B
Asset Breakdown
Total Assets: $4.51B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $930.1M | 20.6% |
| Accounts Receivable | $365.5M | 8.1% |
| Inventory | $396.6M | 8.8% |
| Property, Plant & Equipment | $580.0M | 12.9% |
| Goodwill | $626.1M | 13.9% |
| Intangible Assets | $204.8M | 4.5% |
| Other Assets | $1.41B | 31.2% |
Liabilities Breakdown
Total Liabilities: $1.89B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $97.1M | 5.1% |
| Long-Term Debt | $822.3M | 43.5% |
| Other Liabilities | $971.6M | 51.4% |